Takeda Pharmaceutical (TAK) Non-cash Items (2017 - 2026)

Takeda Pharmaceutical's Non-cash Items history runs 10 years deep, the most recent figure standing at $7.7 billion for Q1 2026.

• In Q1 2026, Non-cash Items fell 2.2% year-over-year to $7.7 billion; the TTM figure through Mar 2026 stood at $7.7 billion (down 2.2% YoY), while the FY2026 annual figure was $8.1 billion, up 1.73% from the prior year.
• Non-cash Items was $7.7 billion for Q1 2026 at Takeda Pharmaceutical, up from $7.0 billion in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $10.9 billion in Q1 2022 to a low of $812.7 million in Q2 2022.
• Historically, Non-cash Items has averaged $4.9 billion across 5 years, with a median of $4.6 billion in 2025.
• The sharpest annual moves came in 2022 and 2024: Non-cash Items tumbled 56.13% in 2022, then surged 50.84% in 2024.
• A 5-year view of Non-cash Items shows it stood at $6.0 billion in 2022, then sank by 31.96% to $4.1 billion in 2023, then soared by 50.84% to $6.2 billion in 2024, then grew by 13.35% to $7.0 billion in 2025, then increased by 10.79% to $7.7 billion in 2026.
• The last three Non-cash Items figures came in at $7.7 billion (Q1 2026), $7.0 billion (Q4 2025), and $4.6 billion (Q3 2025), per Business Quant data.